pharmacology and pharmacy
1,241 projects
pharmaceutical drugs671drug discovery338drug resistance254pharmacokinetics43adverse drug reactions6drug safety4
FP6Excellence award2007–2011Greece
EXPLORNA · Study of rna components by the synthesis of small molecules
FP6Individual fellowship2006–2008Austria
DRUG EFFECTIVENESS · Association of ACEI / ARB with patient and graft survival after renal transplantation.
2 partners · 2 countries
FP6Staff exchange2006–2010Ireland
PHOSCOM · Synthetic routes to useful phosphorus compounds
2 partners · 2 countries
FP6Staff exchange2006–2010Sweden
IMMUNOBIOTA · Tools for integrated studies of the immunoregulatory properties of commensal microbiota
6 partners · 6 countries
FP6Staff exchange2006–2010Ireland
MEMPROT · The technologies of biological membranes
FP6Staff exchange2006–2010Ireland
MRBCI · MicroRNA breast cancer initiative
2 partners · 2 countries
FP6Staff exchange2006–2010Ireland
DEPMAB · Developing expertise in pharmaceutical materials and biomaterials
3 partners · 3 countries
FP6Staff exchange2006–2010Ireland
SIRNA-HCS · Study of the molecular mechanisms of cell migration by using high content screening and siRNA technology
3 partners · 2 countries
FP6Staff exchange2006–2009United Kingdom
PREDICTIVE DIAGNOSIS · Target activation predicts therapeutic benefit
2 partners · 2 countries
FP6Staff exchange2006–2008Greece
BIOMARKER DISCOVERY · Novel post-genomic bioanalytical techniques of metabonomics (metabolomics) in biomedical research and drug discovery
2 partners · 2 countries
FP6Staff exchange2006–2009Ireland
ASTHMA · Micro-fluidic Biochips for trans-endothelial migration of eosinophils for the study of asthma
2 partners · 2 countries
FP6Individual fellowship2006–2008Netherlands
INTERBAC · Molecular and cellular interactions between the plant protective bacterium Bacillus subtilus 49b and the plant pathogen Fusarium oxysporum causing tomato root and foot rot
FP6Individual fellowship2006–2008United Kingdom
REGMIG · Regulation of cell migration by crosstalk between EPH ephrin and FGF receptor signalling
FP6Reintegration grant2006–2008Italy
CORTEX INHIBITION · Self-Inhibition of Interneurons in the Cerebral Cortex
FP6Individual fellowship2006–2008Netherlands
DIFFPHARMA · Diffusion of new pharmaceutical drugs in a global environment
FP6Individual fellowship2006–2006United Kingdom
HUMMEDREF · Welfare-seekers or humanitarian refugees? Immigration and residece in the E.U. for humanitarian and medical reasons: rights, policies, and amp; lived realities.
FP6Individual fellowship2006–2008France
MOL-MENATB · Molecular approach to the study of antibiotic susceptibility of Neisseria meningitidis and of its impact on pathogenesis of meningococcal infection
FP6Individual fellowship2006–2008Sweden
DSCC · Design, synthesis and characterisation of Conotoxins
FP6Individual fellowship2006–2009United Kingdom
SPIROTENUIPESINES · Total Synthesis of the Potent Neurotrophic Factors Spirotenuipesine A and B
2 partners · 2 countries
FP6Individual fellowship2006–2008United Kingdom
P53MUT. REACTIVATORS · Computer-assisted drug discovery and biophysical characterisation of mutant re-activators of the transcription factor p53 as putative tumour therapeutics
FP6Individual fellowship2006–2008France
DENLIG · Comparative structure-function analysis of the dengue virus envelope protein in complex with relevant ligands from the host
FP6Reintegration grant2006–2008Greece
PEPTIDE QUANT · Quantification of bioactive peptides by mass spectrometry - Applicability in drug discovery
FP6Reintegration grant2006–2008Lithuania
PLK1 INHIBITION · Inhibition of Cancer by Disrupting Interaction Between Polo-like Kinase 1 Polo-box Domain and Spindle Targets
FP6Reintegration grant2006–2008Portugal